Business Context and Reporting Period
Company: BioLife Solutions, Inc. (BLFS)
Filing Type: Form 8-K (Current Report)
Report Date: May 7, 2026
Reporting Period: First Quarter ended March 31, 2026
Context: The filing announces the issuance of a press release containing unaudited financial results and operational highlights for the quarter.
Key Financial Metrics
The Form 8-K text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the press release furnished as Exhibit 99.1, which is not included in the source text.
Material Changes
No material changes or comparative financial data versus prior periods are disclosed within the body of this Form 8-K. The filing serves solely to notify the market of the availability of the Q1 2026 results.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary, risks, contingencies, or unusual items. Such details are contained within the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2026 revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter growth rates in the full press release.
- Check for any updated full-year 2026 guidance or operational outlook in the press release.
- Confirm the status of any material contracts or regulatory updates mentioned in the operational highlights.